NEW YORK – A hypercompact CRISPR-Cas enzyme that was discovered in the genomes of huge bacteriophages has expanded genetic target recognition capabilities relative to Cas9 and Cas12, according to a new study published in Science on Thursday.
NEW YORK – A hypercompact CRISPR-Cas enzyme that was discovered in the genomes of huge bacteriophages has expanded genetic target recognition capabilities relative to Cas9 and Cas12, according to a new study published in Science on Thursday.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.